Ascendis Pharma A (ASND) Capital Leases (2012)

Ascendis Pharma A (ASND) posted Capital Leases of $274941.3 for Q4 2012.

Ascendis Pharma A (ASND) Capital Leases (2012) Analysis & Trends

Ascendis Pharma A has reported Capital Leases for 1 years, with the latest figure at $274941.3 in Q4 2012.

Quarterly Capital Leases changed N/A year-over-year to $274941.3 in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $274941.3 (changed N/A YoY) and the FY2012 annual result came in at $272581.3, changed N/A from the prior year.
Capital Leases held at $274941.3 in Q4 2012 per ASND's latest filing.
Over five years, Capital Leases peaked at $274941.3 in Q4 2012 and troughed at $274941.3 in Q4 2012.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Ascendis Pharma A	15.40 Bn	14.73 Bn	268.20 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2012	274,941.27